The histamine H3 receptor as a therapeutic drug target for CNS disordersMark J. Gemkow, David J. Hallett, Andrea M. Cesura et al.|Drug Discovery Today|2009Cited by 181
Discovery of substituted benzyl tetrazoles as histamine H3 receptor antagonistsAdam J. Davenport, David J. Hallett, Christopher C. Stimson et al.|Bioorganic & Medicinal Chemistry Letters|2010Cited by 8